Wise J. Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots. BMJ. 2021;372:n699. https://doi.org/10.1136/bmj.n699.
Gov.UK. UK regulator confirms that people should continue to receive the COVID-19 vaccine AstraZeneca. https://www.gov.uk/government/news/uk-regulator-confirms-that-people-should-continue-to-receive-the-covid-19-vaccine-astrazeneca. Accessed 19 March 2021
EMA. COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets. https://www.ema.europa.eu/en/news/covid-19-vaccine-astrazeneca-benefits-still-outweigh-risks-despite-possible-link-rare-blood-clots. Accessed 19 March 2021.
Althaus K, Marini I, Zlamal J, et al. Antibody-induced procoagulant platelets in severe COVID-19 infection. Blood. 2021;137(8):1061–71. https://doi.org/10.1182/blood.2020008762.
Lee EJ, Cines DB, Gernsheimer T, et al. Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination. Am J Hematol. 2021. https://doi.org/10.1002/ajh.26132.
Merchant HA. CoViD Vaccines and thrombotic events: Possibility of mRNA translation and spike protein synthesis by platelets? BMJ 2021;372:n699/rr-6, https://www.bmj.com/content/372/bmj.n699/rr-6.
WSJ. Scientists say they found cause of rare blood clotting linked to AstraZeneca vaccine. https://www.wsj.com/articles/scientists-say-they-found-cause-of-blood-clotting-linked-to-astrazeneca-vaccine-11616169108. Accessed 19 March 2021.
Doshi P. Pandemrix vaccine: why was the public not told of early warning signs? BMJ. 2018;362:k3948. https://doi.org/10.1136/bmj.k3948.